News

Blueberries Medical Corp.
21.07.2020

Innovative Cannabis Producer Gets Big Investment from Big-time Investor

Investors in both the adult-use / recreational cannabis space, along with the medical-hemp-CBD side of the sector are Click to enlargebeginning to realize one big thing, the industry as a whole has become stagnant and cash-poor, and is in desperate need of a kickstart. That’s why savvy investors are looking for companies thinking outside of the box. Or, the fruit basket, if you will.

16.07.2020

Blueberries Announces Strategic Investor & Closing of $1.0 Million Financing

TORONTO, July 16, 2020 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce it has closed a non-brokered private placement offering (the “Offering”) of C$1,000,000 in principal amount of unsecured convertible debentures (the “Debentures”). The financing included a strategic investment by Mr.

23.06.2020

Top Value Colombian Cannabis Stock: Growing Sales, Extraction

A Latin American licensed producer of medicinal cannabis and cannabis-derived products, Blueberries Medical Corp. (CSE: BBMOTC: BBRRFFRA: 1OA, Forumoperates mainly out of the Bogotá Savannah of central Colombia.

23.04.2020

Blueberries Medical Granted Cultivation License for up to 37 Acres of Outdoor Production at Second Cultivation Property, Signs Letter of Intent to Commence Low-Cost Outdoor Production

TORONTO, April 23, 2020 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce that the Ministry of Justice and Law of the Republic of Colombia has granted a non-psychoactive cultivation license for the  Zipaquira property, making it the Company’s second fully licensed cultivation facility in Colombia. 

01.04.2020

Blueberries Medical Provides Corporate Update

TORONTO, April 01, 2020 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or “Blueberries”), a Latin American producer of medicinal cannabis and cannabis-derived products, is providing the following update on the Company’s recent operating activities.

09.03.2020

Blueberries Medical Corp 2020 At Blueberries,

our number one priority is execution. As we celebrate a year since we got listed on February 6, we are proud to share with you this video which features all we have built and accomplished thus far.

06.02.2020

Blueberries Medical Commissions First Line at Extraction Facility; Secures Supply Agreements with Contract Growers; Further Strengthens Management Team

TORONTO, Feb. 06, 2020 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to provide the following update on the Company’s recent significant operational achievements:

03.01.2020

Blueberries Medical Harvests First Commercial Crop & Progresses Towards Expected Sales in Early 2020

TORONTO, Dec. 03, 2019 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce that it has commenced harvest of its first commercial crops at its 3.2-hectare Guatavita facility located in Bogotá Savannah, Colombia.

01.11.2019

Blueberries Medical Partners with 12,000 Patient Health Clinic and Renowned Academic Foundation and Announces Final Closing of Over-Subscribed Private Placement

TORONTO, Oct. 31, 2019 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a leading Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce that the Company has partnered with the Van Uden International Center for Alternative Medicine (“Van Uden”) and the Juan N.

16.10.2019

‘Los médicos no están bien entrenados sobre el cannabis’: Jahan Marcu

Marcu, experto en la industria, habló con EL TIEMPO sobre los aspectos que se deben regular.

Subscribe to News